Kinfo
Bullfrog AI Holdings Inc. logo

Bullfrog AI Holdings Inc.

BFRGNASDAQHealthcare·US · USD
$0.61
+0.02 (+3.39%)
Prices as of August 10, 2026 · live

Price

Key statistics

Valuation
Market cap10.94M USD
Enterprise value5.99M USD
Trailing P/E-0.97
Forward P/E-2.81
PEG ratio0.02
Price / sales93.77
Price / book2.23
Profitability
Gross margin0.00%
Operating margin-5273.54%
Profit margin18.76%
Return on assets-79.91%
Return on equity-149.35%
Income (TTM)
Revenue116.67K USD
Gross profit21.89K USD
EBITDA-6.15M USD
Net income-6.07M USD
Diluted EPS-$0.54
Rev. growth (YoY)0.00%
Balance sheet
Total cash5.08M USD
Total debt133.89K USD
Debt / equity2.74
Current ratio8.15
Book value / share$0.27
Cash flow (TTM)
Operating cash flow-5.42M USD
Levered free cash flow-3.12M USD
Shares & price
Shares outstanding18.45M
Float16.11M
Held by institutions3.23%
Beta-2.72
50-day MA$0.66
200-day MA$0.80
52-week high$2.04
52-week low$0.43
Dividends
Forward rate
$0.28
Yield
45.90%
Payout ratio
0.00%
Frequency
Annual
Recent payments
  • 2022-05-19$0.07
Earnings (EPS)
DateEst.ActualSurprise2026-07-291.191.35+13.45%2026-05-071.111.22+9.91%2026-02-112.082.10+0.96%
About Bullfrog AI Holdings Inc.

Bullfrog AI Holdings Inc. is a digital biopharmaceutical company that leverages artificial intelligence and machine learning to analyze complex datasets in medicine and healthcare. It offers bfLEAP, an analytical AI/ML platform designed to process preclinical and clinical data for biotechnology and pharmaceutical companies, identifying high-value patient subgroups and optimizing drug development and clinical trials. The company also provides bfPREP, a data preparation tool that harmonizes raw biomedical data into AI-ready formats, and bfARENAS, a scenario-based decision engine for generating risk-balanced R&D portfolio recommendations. Bullfrog AI Holdings Inc. supports precision medicine by uncovering treatment-effect heterogeneity and biomarkers, as demonstrated in applications like pancreatic cancer analytics and collaborations with partners in oncology trials. Founded in 2017 and headquartered in Gaithersburg, Maryland, it operates at the intersection of computational biology and AI to accelerate drug discovery, enhance clinical outcomes, and reduce development costs through explainable AI, graph analytics, and advanced modeling techniques.

Sector
Healthcare
Industry
Health Information Services
CEO
Mr. Vininder Singh
Employees
9
Headquarters
Gaithersburg, MD, United States

Frequently asked questions about Bullfrog AI Holdings Inc.